Scrutinizers Report submitted by PCS Chinmay Lele dated 26 February 2026.
Awaiting price reaction for this filing.
Bijoy Hans Ltd held an Extraordinary General Meeting (EGM) on February 25, 2026, from 3:05 PM to 3:29 PM, where two special resolutions were passed with 100% approval. The first resolution approved changing the company's name from 'Bijoy Hans Limited' to 'Arvaya Healthtech Limited'. The second resolution regularised the appointment of CA Manali Aditya Pandit (DIN: 11495478) as an Independent Director. Out of 7,500,021 total outstanding shares, 4,705,700 shares (62.74% of equity) were polled, with all 5 voting members casting votes entirely in favour and zero against. The e-voting process was conducted through NSDL, and the scrutiniser Mr. Chinmay Mohan Lele (PCS, FCS 12351) submitted the consolidated report on February 26, 2026. Promoters fully supported both resolutions, voting with all their 4,704,800 shares, while only 900 public non-institution shares participated.
The name change to 'Arvaya Healthtech Limited' signals a strategic rebranding, likely pivoting the company towards the healthtech sector, which could change its business direction and investor perception. The name change and new independent director appointment may also help attract investors interested in the healthtech space once regulatory approvals (such as MCA, stock exchange, and ISIN updates) are completed.